Zosano Pharma Corp. (ZSAN) NASDAQ

$0.53 0.01 (1.70%)

Market Cap: $62.14M

As of 12/06/21 04:00 PM EST. Market closed.

(ZSAN)

Zosano Pharma Corp. (ZSAN) NASDAQ

$0.53 0.01 (1.70%)

Market Cap: $62.14M

As of 12/06/21 04:00 PM EST. Market closed.

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium ... read more

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Steven Lo
Full Time Employees
45
URL
Address
34790 Ardentech Ct, California, Fremont, 94555-3657.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Steven Lo
Full Time Employees
45
Address
34790 Ardentech Ct, California, Fremont, 94555-3657.
KEY STATS
Open
$0.51
Previous Close
$0.53
Days Range
$0.52 - $0.59
52 week range
$0.52 - $3.06
Volume
1,118,028
Avg. Volume (30 days)
3,833,765
Market Cap
$62.14M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
118,346,993
Open
$0.51
Previous Close
$0.53
Days Range
$0.52 - $0.59
52 week range
$0.52 - $3.06
Volume
1,118,028
Avg. Volume (30 days)
3,833,765
Market Cap
$62.14M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
118,346,993

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ZOSANO PHARMA CORP
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
GREATHOUSE KENNETH Director Nov 23, 2021 Sale $0.60 10,000 6,018 43,500 Nov 24, 2021, 05:53 PM
Lo Steven Chief Executive Officer Jun 04, 2021 Sale $0.81 13,158 10,592 365,592 Jun 07, 2021, 06:44 PM
KELLERMAN DONALD J VP, Clinical Dev & Med Affairs Jun 04, 2021 Sale $0.81 1,709 1,376 50,337 Jun 07, 2021, 06:42 PM
GREATHOUSE KENNETH Director May 17, 2021 Option Exercise $0.73 21,000 15,311 38,500 May 18, 2021, 07:45 PM
Aisling Capital IV, LP 10% Owner Dec 02, 2019 Option Exercise $1.45 689,655 1,000,000 2,718,226 Dec 06, 2019, 10:23 AM
WALKER JOHN PETER President & CEO Apr 11, 2019 Buy $3.50 100,000 350,000 280,228 Apr 18, 2019, 04:25 PM
Aisling Capital IV, LP 10% Owner Apr 11, 2019 Option Exercise $3.50 428,571 1,499,999 2,028,571 Apr 12, 2019, 04:15 PM
Amzak Capital Management, LLC 10% Owner Feb 26, 2018 Sale $11.00 1,500 16,500 256,091 Feb 28, 2018, 05:38 PM
Amzak Capital Management, LLC 10% Owner Feb 27, 2018 Sale $8.26 5,901 48,760 0 Feb 28, 2018, 05:38 PM
Amzak Capital Management, LLC 10% Owner Feb 27, 2018 Sale $8.36 80,880 675,914 175,211 Feb 28, 2018, 05:38 PM
GREATHOUSE KENNETH Director Dec 06, 2017 Buy $0.61 55,000 33,407 200,000 Dec 08, 2017, 04:24 PM
GREATHOUSE KENNETH Director Dec 01, 2017 Buy $0.62 50,000 31,080 145,000 Dec 04, 2017, 04:05 PM
GREATHOUSE KENNETH Director Nov 30, 2017 Buy $0.62 45,000 27,927 95,000 Dec 04, 2017, 04:05 PM
GREATHOUSE KENNETH Director Nov 15, 2017 Buy $0.58 15,000 8,674 50,000 Nov 16, 2017, 05:28 PM
GREATHOUSE KENNETH Director Nov 14, 2017 Buy $0.64 35,000 22,484 35,000 Nov 16, 2017, 05:28 PM
WALKER JOHN PETER Interim CEO May 25, 2017 Buy $1.37 37,550 51,338 206,894 May 26, 2017, 05:53 PM
WALKER JOHN PETER Interim CEO May 24, 2017 Buy $1.34 36,166 48,553 169,344 May 26, 2017, 05:53 PM
Erbez Georgia CFO and Chief Business Officer May 25, 2017 Buy $1.32 68,000 89,760 115,750 May 25, 2017, 08:55 PM
WALKER JOHN PETER Interim CEO May 25, 2017 Buy $1.37 37,550 51,338 206,894 May 25, 2017, 08:45 PM
WALKER JOHN PETER Interim CEO May 24, 2017 Buy $1.34 36,166 48,553 169,344 May 25, 2017, 08:45 PM
Alataris Konstantinos President, CEO Mar 20, 2017 Option Exercise $1.45 127,389 184,714 254,778 Mar 22, 2017, 05:39 PM
BARRETT M JAMES 10% Owner Feb 13, 2017 Sale $2.01 1,099,996 2,211,432 952,809 Feb 14, 2017, 05:37 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Feb 13, 2017 Sale $2.01 1,099,996 2,211,432 952,809 Feb 14, 2017, 05:36 PM
BARRETT M JAMES 10% Owner Sep 16, 2016 Sale $0.75 7,471 5,603 2,052,805 Sep 20, 2016, 04:39 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Sep 16, 2016 Sale $0.75 7,471 5,603 2,052,805 Sep 20, 2016, 04:39 PM
BARRETT M JAMES 10% Owner Sep 13, 2016 Sale $0.74 10,000 7,400 2,060,276 Sep 15, 2016, 04:31 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Sep 13, 2016 Sale $0.74 10,000 7,400 2,060,276 Sep 15, 2016, 04:30 PM
BARRETT M JAMES 10% Owner Aug 29, 2016 Sale $1.01 50,000 50,440 2,070,276 Aug 31, 2016, 04:36 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Aug 29, 2016 Sale $1.01 50,000 50,440 2,070,276 Aug 31, 2016, 04:35 PM
BARRETT M JAMES 10% Owner Aug 24, 2016 Sale $1.21 1,200 1,452 2,120,276 Aug 26, 2016, 05:08 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Aug 24, 2016 Sale $1.21 1,200 1,452 2,120,276 Aug 26, 2016, 05:07 PM
Erbez Georgia Interim CFO Aug 19, 2016 Buy $1.32 47,750 63,030 47,750 Aug 22, 2016, 07:46 PM
Lewis Hayley VP, Reg Affairs & Quality Aug 19, 2016 Buy $1.32 4,775 6,303 4,775 Aug 22, 2016, 07:29 PM
KELLERMAN DONALD J VP, Clinical Dev & Med Affairs Aug 19, 2016 Buy $1.32 15,920 21,014 15,920 Aug 22, 2016, 07:18 PM
WALKER JOHN PETER Director Aug 19, 2016 Buy $1.32 63,700 84,084 63,700 Aug 22, 2016, 07:05 PM
Alataris Konstantinos President, CEO Aug 19, 2016 Buy $1.32 127,389 168,153 127,389 Aug 22, 2016, 06:45 PM
XANTHOPOULOS KLEANTHIS G Director Aug 19, 2016 Buy $1.32 15,920 21,014 21,920 Aug 22, 2016, 05:11 PM
BARRETT M JAMES 10% Owner Jul 20, 2016 Sale $1.24 14,158 17,550 2,130,465 Jul 21, 2016, 04:32 PM
BARRETT M JAMES 10% Owner Jul 19, 2016 Sale $1.17 534 625 2,144,623 Jul 21, 2016, 04:32 PM
BARRETT M JAMES 10% Owner Jul 21, 2016 Sale $1.33 8,989 11,957 2,121,476 Jul 21, 2016, 04:32 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jul 21, 2016 Sale $1.33 8,989 11,957 2,121,476 Jul 21, 2016, 04:31 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jul 20, 2016 Sale $1.24 14,158 17,550 2,130,465 Jul 21, 2016, 04:31 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jul 19, 2016 Sale $1.17 534 625 2,144,623 Jul 21, 2016, 04:31 PM
BARRETT M JAMES 10% Owner Jul 13, 2016 Sale $1.20 13,382 16,060 2,145,157 Jul 15, 2016, 04:34 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jul 13, 2016 Sale $1.20 13,382 16,060 2,145,157 Jul 15, 2016, 04:33 PM
BARRETT M JAMES Director Jan 30, 2015 Option Exercise $9.35 341,201 3,190,229 2,135,082 Feb 02, 2015, 01:33 PM
BARRETT M JAMES Director Jan 30, 2015 Buy $11.00 23,457 258,027 2,158,539 Feb 02, 2015, 01:33 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jan 30, 2015 Option Exercise $9.35 341,201 3,190,229 2,135,082 Feb 02, 2015, 01:32 PM
New Enterprise Associates 12, Limited Partnership 10% Owner Jan 30, 2015 Buy $11.00 23,457 258,027 2,158,539 Feb 02, 2015, 01:32 PM
BioMed Realty Trust Inc 10% Owner Jan 30, 2015 Option Exercise $9.35 317,409 2,967,774 1,896,982 Feb 02, 2015, 01:17 PM
BioMed Realty Trust Inc 10% Owner Jan 30, 2015 Option Exercise $9.35 64,661 604,580 518,904 Feb 02, 2015, 01:17 PM
BioMed Realty Trust Inc 10% Owner Jan 30, 2015 Buy $11.00 26,543 291,973 545,447 Feb 02, 2015, 01:17 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
GREATHOUSE KENNETH Director 11/23/2021 6,018
Lo Steven Chief Executive Officer 06/04/2021 10,592
KELLERMAN DONALD J VP, Clinical Dev & Med Affairs 06/04/2021 1,376
GREATHOUSE KENNETH Director 05/17/2021 15,311
Aisling Capital IV, LP 10% Owner 12/02/2019 1,000,000
WALKER JOHN PETER President & CEO 04/11/2019 350,000
Aisling Capital IV, LP 10% Owner 04/11/2019 1,499,999
Amzak Capital Management, LLC 10% Owner 02/26/2018 16,500
Amzak Capital Management, LLC 10% Owner 02/27/2018 48,760
Amzak Capital Management, LLC 10% Owner 02/27/2018 675,914
GREATHOUSE KENNETH Director 12/06/2017 33,407
GREATHOUSE KENNETH Director 12/01/2017 31,080
GREATHOUSE KENNETH Director 11/30/2017 27,927
GREATHOUSE KENNETH Director 11/15/2017 8,674
GREATHOUSE KENNETH Director 11/14/2017 22,484
WALKER JOHN PETER Interim CEO 05/25/2017 51,338
WALKER JOHN PETER Interim CEO 05/24/2017 48,553
Erbez Georgia CFO and Chief Business Officer 05/25/2017 89,760
WALKER JOHN PETER Interim CEO 05/25/2017 51,338
WALKER JOHN PETER Interim CEO 05/24/2017 48,553
Alataris Konstantinos President, CEO 03/20/2017 184,714
BARRETT M JAMES 10% Owner 02/13/2017 2,211,432
New Enterprise Associates 12, Limited Partnership 10% Owner 02/13/2017 2,211,432
BARRETT M JAMES 10% Owner 09/16/2016 5,603
New Enterprise Associates 12, Limited Partnership 10% Owner 09/16/2016 5,603
BARRETT M JAMES 10% Owner 09/13/2016 7,400
New Enterprise Associates 12, Limited Partnership 10% Owner 09/13/2016 7,400
BARRETT M JAMES 10% Owner 08/29/2016 50,440
New Enterprise Associates 12, Limited Partnership 10% Owner 08/29/2016 50,440
BARRETT M JAMES 10% Owner 08/24/2016 1,452
New Enterprise Associates 12, Limited Partnership 10% Owner 08/24/2016 1,452
Erbez Georgia Interim CFO 08/19/2016 63,030
Lewis Hayley VP, Reg Affairs & Quality 08/19/2016 6,303
KELLERMAN DONALD J VP, Clinical Dev & Med Affairs 08/19/2016 21,014
WALKER JOHN PETER Director 08/19/2016 84,084
Alataris Konstantinos President, CEO 08/19/2016 168,153
XANTHOPOULOS KLEANTHIS G Director 08/19/2016 21,014
BARRETT M JAMES 10% Owner 07/20/2016 17,550
BARRETT M JAMES 10% Owner 07/19/2016 625
BARRETT M JAMES 10% Owner 07/21/2016 11,957
New Enterprise Associates 12, Limited Partnership 10% Owner 07/21/2016 11,957
New Enterprise Associates 12, Limited Partnership 10% Owner 07/20/2016 17,550
New Enterprise Associates 12, Limited Partnership 10% Owner 07/19/2016 625
BARRETT M JAMES 10% Owner 07/13/2016 16,060
New Enterprise Associates 12, Limited Partnership 10% Owner 07/13/2016 16,060
BARRETT M JAMES Director 01/30/2015 3,190,229
BARRETT M JAMES Director 01/30/2015 258,027
New Enterprise Associates 12, Limited Partnership 10% Owner 01/30/2015 3,190,229
New Enterprise Associates 12, Limited Partnership 10% Owner 01/30/2015 258,027
BioMed Realty Trust Inc 10% Owner 01/30/2015 2,967,774
BioMed Realty Trust Inc 10% Owner 01/30/2015 604,580
BioMed Realty Trust Inc 10% Owner 01/30/2015 291,973
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
2.88%
1Q
09/30/2021
03/31/2021
5.15%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
2.88%
1Q
03/31/2021
5.15%
2Q